Siga este link para ver outros tipos de publicações sobre o tema: Diseases.

Artigos de revistas sobre o tema "Diseases"

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Diseases".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.

1

Limpert, E., e P. Bartoš. "Wind-Dispersed Nomadic Diseases: Conclusions for Disease Resistance". Czech Journal of Genetics and Plant Breeding 38, No. 3-4 (1 de agosto de 2012): 150–52. http://dx.doi.org/10.17221/6256-cjgpb.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Dehuri, Priyadarshini, Debasis Gochhait, Debdatta Basu e Neelaiah Siddaraju. "Rosai-Dorfman Disease: An Imposter of Plasma Cell Rich Diseases". Annals of Pathology and Laboratory Medicine 2, n.º 12 (17 de dezembro de 2018): C178–181. http://dx.doi.org/10.21276/apalm.2102.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Balaji, SM. "Noncommunicable diseases and dental diseases". Indian Journal of Dental Research 29, n.º 6 (2018): 699. http://dx.doi.org/10.4103/ijdr.ijdr_895_18.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Heinz, Don J., e Steve A. Ferreira. "Diseases of sugarcane. Major diseases". Field Crops Research 19, n.º 1 (agosto de 1988): 77–78. http://dx.doi.org/10.1016/0378-4290(88)90037-8.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

MATSUMOTO, KEIZO. "Emerging infectious diseases and insensible bacillus infectious diseases. Emerging infectious diseases. Influenza virus infection diseases." Nihon Naika Gakkai Zasshi 86, n.º 11 (1997): 2033–38. http://dx.doi.org/10.2169/naika.86.2033.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Kadirovna, Muratova Saodat, Shukurova Nodira Tillayevna, Baratov Bobur e Teshayev Shoxjahon. "PREDICTIVE MODELING OF THE PROBABILITY OF DEVELOPING PERIODONTAL DISEASES IN PATIENTS WITH CARDIOVASCULAR DISEASE". European International Journal of Multidisciplinary Research and Management Studies 4, n.º 4 (1 de abril de 2024): 65–70. http://dx.doi.org/10.55640/eijmrms-04-04-10.

Texto completo da fonte
Resumo:
Currently, the forecast of the development of pathology is an important part of all branches of healthcare. [3,4,5]. However, despite the importance and scientific and practical significance of forecasting in dentistry, at present we have not found information about predictive models of individual risk of developing periodontitis in patients with hypertension.
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

&NA;. "Diseases". Inpharma Weekly &NA;, n.º 872 (janeiro de 1993): 5. http://dx.doi.org/10.2165/00128413-199308720-00007.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Kumagai, Shunichi. "7. Collagen Diseases and Allergic Diseases". Nihon Naika Gakkai Zasshi 97, n.º 12 (2008): 2991–97. http://dx.doi.org/10.2169/naika.97.2991.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Tatsumi, Koichiro. "Respiratory diseases as lifestyle-related diseases". Health Evaluation and Promotion 39, n.º 6 (2012): 821–28. http://dx.doi.org/10.7143/jhep.39.821.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

Arma, Utmi, e Nadhifah Salsabila. "Peri-Implant Diseases and Gastrointestinal Diseases". Archives of Orofacial Sciences 16, Supp. 1 (22 de setembro de 2021): 1–4. http://dx.doi.org/10.21315/aos2021.16.s1.1.

Texto completo da fonte
Resumo:
Peri-implant diseases are serious problems that plagues today’s dentistry, both in terms of therapy and epidemiology. With the expansion of implantology practice and the increasing number of implants placed annually, the frequency of peri-implant diseases has greatly expanded. The clinical manifestations, in the absence of a globally established classification, are peri-implant mucositis and peri-implantitis, the counterparts of gingivitis and periodontitis, respectively. However, many doubts remain about their features. Official diagnostic criteria, globally recognised by the dental community, have not yet been introduced. The review presented possible association between gastrointestinal diseases and peri-implant diseases. Previous studies had revealed the association with significantly higher levels of bacteria in patient’s gastrointestinal disease at either gingivitis or in periodontitis site. Additionally, pathogenesis of the periodontitis is similar to peri-implant diseases.
Estilos ABNT, Harvard, Vancouver, APA, etc.
11

Yokoyama, Takashi, e Shirou Mohri. "Prion Diseases and Emerging Prion Diseases". Current Medicinal Chemistry 15, n.º 9 (1 de abril de 2008): 912–16. http://dx.doi.org/10.2174/092986708783955437.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
12

Gorbunova, Victoria N. "Congenital metabolic diseases. Lysosomal storage diseases". Pediatrician (St. Petersburg) 12, n.º 2 (11 de agosto de 2021): 73–83. http://dx.doi.org/10.17816/ped12273-83.

Texto completo da fonte
Resumo:
The classification and epidemiology of hereditary metabolic disorders are presented. That is a large group consisting from more them 800 monogenic diseases, each of which caused by inherited deficiency of certain metabolic fate. Many of these disorders are extremely rare, but their total incidence in the population is close to 1:10005000. Lysosomal storage diseases (LSD) resulting from inherited deficiency in lysosomal functions occupy a special place among hereditary metabolic disorders. The defects of catabolism cause the accumulation of undigested or partially digested macromolecules in lysosomes (that is, storage), which can result in cellular damage. About 60 diseases take part in this group with total incidence of about 1:70008000. LSDs typically present in infancy and childhood, although adult-onset forms also occur. Most of them have a progressive neurodegenerative clinical course, although symptoms in other organ systems are frequent. The etiology and pathogenetic aspects of their main clinical entities: mucopolysaccharidosis, glycolipidosis, mucolipidosis, glycoproteinosis, etc, are presented. Mucopolysaccharidoses caused by malfunctioning of lysosomal enzymes needed to break down glycosaminoglycans are more frequent among LSD. Sphingolipidoses caused by defects of lipid catabolism are second for frequency group of LSD. The state-of-art in field of newborn screening. clinical, biochemical and molecular diagnostics of these grave diseases are discussed. The main directions of modern lysosomal storage diseases therapy are characterized: transplantation of hematopoietic stem cells; enzyme replacement therapy; therapy with limitation of substrate synthesis (substrate-reducing therapy); pharmacological chaperone therapy. Perspective directions for LSD therapy are gene therapy and genome editing which are at advanced preclinical stages.
Estilos ABNT, Harvard, Vancouver, APA, etc.
13

Paramjyothi, G. "Respiratory Diseases and Coronary Artery Diseases". Indian Journal of Cardiovascular Disease in Women WINCARS 02, n.º 01 (março de 2017): 056–67. http://dx.doi.org/10.1055/s-0038-1656461.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
14

Wurtz, Rebecca. "Psychiatric Diseases Presenting as Infectious Diseases". Clinical Infectious Diseases 26, n.º 4 (abril de 1998): 924–32. http://dx.doi.org/10.1086/513936.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
15

Ravilochan, K., e Kenneth Tyler. "Human Transmissible Neurodegenerative Diseases (Prion Diseases)". Seminars in Neurology 12, n.º 03 (setembro de 1992): 178–92. http://dx.doi.org/10.1055/s-2008-1041174.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
16

Lee, Jeongmin, Su Yeon Kim, Kyu Jam Hwang, Young Ran Ju e Hee-Jong Woo. "Prion Diseases as Transmissible Zoonotic Diseases". Osong Public Health and Research Perspectives 4, n.º 1 (fevereiro de 2013): 57–66. http://dx.doi.org/10.1016/j.phrp.2012.12.008.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
17

Mizuno, T. "1299 – Are mental diseases synaptic diseases?" European Psychiatry 28 (janeiro de 2013): 1. http://dx.doi.org/10.1016/s0924-9338(13)76357-0.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
18

IWAMOTO, AIKICHI. "Infectious diseases. 1. Emerging infectious diseases and re-merging infectious diseases." Nihon Naika Gakkai Zasshi 88, n.º 3 (1999): 517–21. http://dx.doi.org/10.2169/naika.88.517.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
19

Deiana, Giovanna, Antonella Arghittu, Marco Dettori e Paolo Castiglia. "One World, One Health: Zoonotic Diseases, Parasitic Diseases, and Infectious Diseases". Healthcare 12, n.º 9 (29 de abril de 2024): 922. http://dx.doi.org/10.3390/healthcare12090922.

Texto completo da fonte
Resumo:
When we take into account how the boundaries between human, animal, and environmental health are inextricably linked and increasingly intertwined, it comes as no surprise that the One Health approach has assumed an unprecedented level of importance over the past decade [...]
Estilos ABNT, Harvard, Vancouver, APA, etc.
20

Prasad, Dr S. R. "Neglected Tropical Diseases". JOURNAL OF CLINICAL AND BIOMEDICAL SCIENCES 03, n.º 1 (15 de março de 2013): 1–2. http://dx.doi.org/10.58739/jcbs/v03i1.7.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
21

Smith, John A. "Noninfectious Diseases, Metabolic Diseases, Toxicities, and Neoplastic Diseases of South American Camelids". Veterinary Clinics of North America: Food Animal Practice 5, n.º 1 (março de 1989): 101–43. http://dx.doi.org/10.1016/s0749-0720(15)31006-9.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
22

Ramamurthy, Mahesh babu, Daniel Y. T. Goh e Michael Teik Chung Lim. "Rare Lung Diseases: Interstitial Lung Diseases and Lung Manifestations of Rheumatological Diseases". Indian Journal of Pediatrics 82, n.º 10 (20 de agosto de 2015): 956–61. http://dx.doi.org/10.1007/s12098-015-1867-3.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
23

Sari, Refik Ali. "Interstitial Lung Diseases In Collagen Vascular Diseases". Güncel Göğüs Hastalıkları Serisi 2, n.º 3 (18 de janeiro de 2016): 358–73. http://dx.doi.org/10.5152/gghs.2014.026.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
24

Wang, Chrong-Reen, e Hung-Wen Tsai. "Autoimmune liver diseases in systemic rheumatic diseases". World Journal of Gastroenterology 28, n.º 23 (21 de junho de 2022): 2527–45. http://dx.doi.org/10.3748/wjg.v28.i23.2527.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
25

Moutsopoulos, Haralampos M. "Autoimmune rheumatic diseases: One or many diseases?" Journal of Translational Autoimmunity 4 (2021): 100129. http://dx.doi.org/10.1016/j.jtauto.2021.100129.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
26

Kouanda, Bakey, Zeeshan Sattar e Patrick Geraghty. "Periodontal Diseases: Major Exacerbators of Pulmonary Diseases?" Pulmonary Medicine 2021 (2 de novembro de 2021): 1–10. http://dx.doi.org/10.1155/2021/4712406.

Texto completo da fonte
Resumo:
Periodontal diseases are a range of polymicrobial infectious disorders, such as gingivitis and periodontitis, which affect tooth-supporting tissues and are linked to playing a role in the exacerbation of several pulmonary diseases. Pulmonary diseases, such as pneumonia, chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, COVID-19, and bronchiectasis, significantly contribute to poor quality of life and mortality. The association between periodontal disease and pulmonary outcomes is an important topic and requires further attention. Numerous resident microorganisms coexist in the oral cavity and lungs. However, changes in the normal microflora due to oral disease, old age, lifestyle habits, or dental intervention may contribute to altered aspiration of oral periodontopathic bacteria into the lungs and changing inflammatory responses. Equally, periodontal diseases are associated with the longitudinal decline in spirometry lung volume. Several studies suggest a possible beneficial effect of periodontal therapy in improving lung function with a decreased frequency of exacerbations and reduced risk of adverse respiratory events and morbidity. Here, we review the current literature outlining the link between the oral cavity and pulmonary outcomes and focus on the microflora of the oral cavity, environmental and genetic factors, and preexisting conditions that can impact oral and pulmonary outcomes.
Estilos ABNT, Harvard, Vancouver, APA, etc.
27

Jeong, Sung Hwan. "Interstitial Lung Diseases in Collagen Vascular Diseases". Journal of the Korean Medical Association 52, n.º 1 (2009): 30. http://dx.doi.org/10.5124/jkma.2009.52.1.30.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
28

Linssen, A., e T. E. Feltkamp. "B27 positive diseases versus B27 negative diseases." Annals of the Rheumatic Diseases 47, n.º 5 (1 de maio de 1988): 431–39. http://dx.doi.org/10.1136/ard.47.5.431.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
29

Levine, Jerome F. "Infectious Diseases: Hot Topics:Infectious Diseases: Hot Topics". Clinical Infectious Diseases 38, n.º 8 (15 de abril de 2004): 1197–98. http://dx.doi.org/10.1086/383064.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
30

Mandal, B. K., e P. F. Schofield. "ABC of colorectal diseases. Tropical colonic diseases." BMJ 305, n.º 6854 (12 de setembro de 1992): 638–41. http://dx.doi.org/10.1136/bmj.305.6854.638.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
31

Sand, Freja Lærke, e Simon Francis Thomsen. "Skin diseases of the vulva: Infectious diseases". Journal of Obstetrics and Gynaecology 37, n.º 7 (11 de abril de 2017): 840–48. http://dx.doi.org/10.1080/01443615.2017.1306696.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
32

Aronson, Jeff. "Rare diseases, orphan drugs, and orphan diseases". BMJ 333, n.º 7559 (13 de julho de 2006): 127. http://dx.doi.org/10.1136/bmj.333.7559.127.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
33

Dorri, M. "Periodontal diseases: New classification for periodontal diseases". British Dental Journal 225, n.º 8 (outubro de 2018): 686. http://dx.doi.org/10.1038/sj.bdj.2018.941.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
34

Saudubray, J. M. "Status of lysosomal diseases amongst metabolic diseases". La Revue de Médecine Interne 27 (março de 2006): S11—S13. http://dx.doi.org/10.1016/s0248-8663(06)80004-4.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
35

FUKUDA, Yoshihiro. "Cytokines and diseases. Cytokines and liver diseases." Nihon Naika Gakkai Zasshi 80, n.º 9 (1991): 1409–13. http://dx.doi.org/10.2169/naika.80.1409.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
36

Kanegane, Hirokazu. "Inflammatory bowel diseases and primary immunodeficiency diseases". Immunological Medicine 41, n.º 4 (2 de outubro de 2018): 154–61. http://dx.doi.org/10.1080/25785826.2018.1556025.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
37

Weidlich, Patrícia, Renata Cimões, Claudio Mendes Pannuti e Rui Vicente Oppermann. "Association between periodontal diseases and systemic diseases". Brazilian Oral Research 22, suppl 1 (agosto de 2008): 32–43. http://dx.doi.org/10.1590/s1806-83242008000500006.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
38

Shaw, Elizabeth A., e Anne M. Stevens. "Are pediatric autoimmune diseases primarily genetic diseases?" Current Opinion in Rheumatology 20, n.º 5 (setembro de 2008): 589–94. http://dx.doi.org/10.1097/bor.0b013e328307f283.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
39

Withrock, Isabelle C., Stephen J. Anderson, Matthew A. Jefferson, Garrett R. McCormack, Gregory S. A. Mlynarczyk, Aron Nakama, Jennifer K. Lange et al. "Genetic diseases conferring resistance to infectious diseases". Genes & Diseases 2, n.º 3 (setembro de 2015): 247–54. http://dx.doi.org/10.1016/j.gendis.2015.02.008.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
40

Casella, Giovanni, Vincenzo Villanacci, Camillo Di Bella, Elisabetta Antonelli, Vittorio Baldini e Gabrio Bassotti. "Pulmonary diseases associated with inflammatory bowel diseases". Journal of Crohn's and Colitis 4, n.º 4 (outubro de 2010): 384–89. http://dx.doi.org/10.1016/j.crohns.2010.02.005.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
41

PR, Nandeesh Kumar. "Anti-neurofascin demyelinating diseases (Anti-NF diseases)". International Journal of Advance Research in Medical Surgical Nursing 6, n.º 1 (1 de janeiro de 2024): 26–29. http://dx.doi.org/10.33545/surgicalnursing.2024.v6.i1a.164.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
42

Ha, Tai-You. "MicroRNAs in Human Diseases: From Autoimmune Diseases to Skin, Psychiatric and Neurodegenerative Diseases". Immune Network 11, n.º 5 (2011): 227. http://dx.doi.org/10.4110/in.2011.11.5.227.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
43

KATSUMATA, TATSUYA. "Emerging infectious diseases and insensible bacillus infectious diseases. Emerging infectious diseases. Cryptosporidium infection." Nihon Naika Gakkai Zasshi 86, n.º 11 (1997): 2058–63. http://dx.doi.org/10.2169/naika.86.2058.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
44

Oxley, Dwight K. "Endocrine Diseases". Archives of Pathology & Laboratory Medicine 127, n.º 3 (1 de março de 2003): 381–82. http://dx.doi.org/10.5858/2003-127-0381-ed.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
45

Zelmer, Derek A., D. D. Despommier, R. W. Gwadz, P. J. Hotez e C. A. Knirsch. "Parasitic Diseases". Journal of Parasitology 87, n.º 6 (dezembro de 2001): 1414. http://dx.doi.org/10.2307/3285310.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
46

Araujo, Abelardo Q.-C. "Prionic diseases". Arquivos de Neuro-Psiquiatria 71, n.º 9B (setembro de 2013): 731–37. http://dx.doi.org/10.1590/0004-282x201301461.

Texto completo da fonte
Resumo:
Prion diseases are neurodegenerative illnesses due to the accumulation of small infectious pathogens containing protein but apparently lacking nucleic acid, which have long incubation periods and progress inexorably once clinical symptoms appear. Prions are uniquely resistant to a number of normal decontaminating procedures. The prionopathies [Kuru, Creutzfeldt-Jakob disease (CJD) and its variants, Gerstmann-Sträussler-Scheinker (GSS) syndrome and fatal familial insomnia (FFI)] result from accumulation of abnormal isoforms of the prion protein in the brains of normal animals on both neuronal and non-neuronal cells. The accumulation of this protein or fragments of it in neurons leads to apoptosis and cell death. There is a strong link between mutations in the gene encoding the normal prion protein in humans (PRNP) - located on the short arm of chromosome 20 – and forms of prion disease with a familial predisposition (familial CJD, GSS, FFI). Clinically a prionopathy should be suspected in any case of a fast progressing dementia with ataxia, myoclonus, or in individuals with pathological insomnia associated with dysautonomia. Magnetic resonance imaging, identification of the 14-3-3 protein in the cerebrospinal fluid, tonsil biopsy and genetic studies have been used for in vivo diagnosis circumventing the need of brain biopsy. Histopathology, however, remains the only conclusive method to reach a confident diagnosis. Unfortunately, despite numerous treatment efforts, prionopathies remain short-lasting and fatal diseases.
Estilos ABNT, Harvard, Vancouver, APA, etc.
47

Gamage, R. "Prion diseases". Ceylon Medical Journal 45, n.º 1 (20 de janeiro de 2015): 3. http://dx.doi.org/10.4038/cmj.v45i1.7941.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
48

Rameev, V. V., L. V. Lysenko (Kozlovskaya), M. V. Bogdanova e S. V. Moiseev. "Autoinflammatory diseases". Clinical pharmacology and therapy 29, n.º 4 (15 de novembro de 2020): 49–60. http://dx.doi.org/10.32756/0869-5490-2020-4-49-60.

Texto completo da fonte
Resumo:
Autoinflammatory diseases are a group of disorders caused by a dysregulation of the innate immune system. Unlike autoimmune diseases, they are not associated with changes in humoral or cellular immunity. The authors review the current classification, clinical manifestations and treatment of various systemic autoinflammatory diseases, including cryopirinassociated periodic syndrome, familial Mediterranean fever, HIDS, and TRAPS.
Estilos ABNT, Harvard, Vancouver, APA, etc.
49

Palm, Mary E., e R. J. Hillocks. "Cotton Diseases". Mycologia 86, n.º 2 (março de 1994): 305. http://dx.doi.org/10.2307/3760659.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
50

Perry, Martha, e Bianca A. Allison. "Gonorrheal Diseases". Pediatrics in Review 39, n.º 8 (agosto de 2018): 427–29. http://dx.doi.org/10.1542/pir.2017-0120.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!

Vá para a bibliografia